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Congenital Heart Disease

Aortic Valve Disease in Turner Syndrome
Vandana Sachdev, MD,* Lea Ann Matura, RNP, PHD,† Stanislav Sidenko, BA,*
Vincent B. Ho, MD, MBA,‡ Andrew E. Arai, MD,* Douglas R. Rosing, MD,*
Carolyn A. Bondy, MD†
Bethesda, Maryland
Objectives

Our goal was to determine the prevalence and characteristics of aortic valve disease in girls and women with
monosomy for the X chromosome, or Turner syndrome (TS).

Background

Complications from congenital aortic valve disease are a major source of premature mortality in TS, but accurate data on the prevalence of aortic valve abnormalities and their association with aortic root dilation are not
available.

Methods

This prospective study characterized the aortic valve and proximal aorta in 253 individuals with TS age 7 to 67
years using transthoracic echocardiography as our primary screening tool, supplemented with magnetic resonance imaging.

Results

Transthoracic echocardiography revealed a normal tricuspid aortic valve (TAV) in 172 and a bicuspid aortic valve
(BAV) in 66 subjects. Transthoracic echocardiography could not visualize the aortic valve in 15 of 253 or 6%.
Magnetic resonance imaging diagnosed 12 of 15 of these cases (8 BAV and 4 TAV), so that only 3 of 253 (1.2%)
could not be visualized by either modality. The aortic valve was bicuspid in 74 of 250 (30%) adequately imaged
subjects. The prevalence was equal in pediatric (⬍18 years, n ⫽ 89) and adult populations. Over 95% of abnormal aortic valves in TS resulted from fusion of the right and left coronary leaflets. Ascending aortic diameters
were significantly greater at the annulus, sinuses, sinotubular junction, and ascending aorta in the BAV group,
with aortic root dilation in 25% of subjects with BAV versus 5% of those with TAV.

Conclusions

Girls and women with TS need focused screening of the aortic valve and root to identify the many asymptomatic
individuals with abnormal valvular structure and/or aortic root dilation. (J Am Coll Cardiol 2008;51:1904–9)
© 2008 by the American College of Cardiology Foundation

Turner syndrome (TS) occurs in phenotypic female patients
missing all or part of 1 sex chromosome in all or most
somatic cells. It is the most common genetic disorder of
female patients, affecting approximately 1 in 2,500 live
female births (1,2). There is a broad phenotypic spectrum in
this syndrome, but almost all have short stature and early
ovarian failure (3,4).With current medical treatment including growth hormone and estrogen, girls may attain nearnormal adult stature and feminization. The major source of
premature mortality in TS is congenital cardiovascular
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disease, which is responsible for the demise of the great
majority of TS fetuses by the second trimester (5,6).
Clinically severe defects, mainly aortic coarctation and/or
aortic valve disease, affect ⬃10% of live-born girls with TS.
Transthoracic echocardiographic surveys of pediatric clinic
TS patients in Europe suggest that congenital cardiovascular defects are found in 20% to 30% of young individuals,
with bicuspid aortic valve (BAV) reported in 10% to
18% (7,8).
These studies did not focus on the aortic valve and did
not provide morphologic detail of BAV structure or associated aortic diameters. Moreover, the actual prevalence of
BAV in these studies remains uncertain because they did
not report the number or percent of cases that could not be
ascertained. Transthoracic echocardiography studies focused solely on defining aortic valve structure report inability to visualize or define aortic valve structure in 10% to 40%
of subjects, with particular difficulty defining BAVs (9,10).
Identifying a BAV in asymptomatic individuals is important
because they are at increased risk for infective endocarditis,
valve dysfunction, and for aortic aneurysm, which may
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require intervention to prevent dissection or rupture. This
issue is a major concern in TS, since the risk of aortic
dissection is greatly increased (11–14).
The present study aimed to define the structure of the
aortic valve in a large group of girls and women with TS
participating in a National Institutes of Health (NIH)
natural history study. The primary examination was transthoracic echocardiography focused specifically on the aortic
valve and ascending aorta. In cases where the valve was not
adequately visualized by echocardiography, cardiac magnetic
resonance imaging (MRI) studies were examined for aortic
valve morphology.
Methods
Study subjects. Study participants were part of an ongoing
genotype-phenotype research study approved by the National Institute of Child Health Institutional Review Board.
All adult participants and parents of minors gave written
informed consent, and minors gave written informed assent.
The study included bone mineral density, body composition, and metabolic function studies, as well as cardiovascular assessment. Study subjects were recruited through
notices on the NIH web site and on the Turner Syndrome
Society USA web site. There was no specific outreach to
heart patients or providers. Inclusion criteria were phenotypic female subjects 7 years and older who had a 50-cell
peripheral karyotype with ⱖ70% of cells demonstrating loss
or partial loss of the second sex chromosome. One patient
with a prosthetic aortic valve was excluded from the study.
Two other patients had endovascular valvuloplasty, and
these were included. Neck webbing (pterygium colli) was
defined as redundant cervical skin folds arcing out from
mastoid at ear lobe level to the acromium. The webbed neck
has a trapezoidal shape and is always associated with a very
low posterior hairline and usually with low set, mal-rotated
ears, and down-sloping or hooded appearing eyes. All of
these features are caused by the stretching of the developing
fetal head and neck skin and scalp over the cystic hygromata.
Echocardiography. Transthoracic 2-dimensional and
Doppler echocardiography were obtained on all subjects
using commercially available echocardiography machines.
The standard parasternal, apical, and subcostal views were
obtained with the participants in the left lateral recumbent
position. The images were stored digitally and on VHS
videotape for analysis. Cardiac measurements were performed according to the American Society of Echocardiography guidelines (15). Two authors (V.S. and S.S.) reviewed
all studies for evaluation of the aortic valve morphology and
measurement of aortic diameters. Readers were blinded to
prior clinical history and results of other imaging studies.
The BAV was defined as partial or complete fusion of 2
cusps, with or without a central raphe, resulting in partial or
complete absence of a functional commissure between the
fused leaflets (16). Abnormal aortic valves were further
classified as “right-left” (fusion of right coronary and non-
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coronary cusps) or “anteriorAbbreviations
and Acronyms
posterior” (fusion of right and
left coronary cusps) according to
BAV ⴝ bicuspid aortic
previous studies (17). Supporting
valve
features of abnormal valves inBSA ⴝ body surface area
cluded doming, thickening, or
MRI ⴝ magnetic resonance
redundancy of leaflets, eccentric
imaging
closure, or the presence of signifNIH ⴝ National Institutes
icant aortic regurgitation. Aortic
of Health
diameters were measured using a
TAV ⴝ tricuspid aortic
leading-edge to leading-edge
valve
technique at end diastole and
TS ⴝ Turner syndrome
were averaged for 3 beats at each
site. Measurements were taken at
the aortic annulus, sinuses of Valsalva, sinotubular junction,
and 1 cm above the sinotubular junction. Some of the
subjects in this study were reported in an earlier study
investigating the association between fetal lymphedema and
congenital heart defects in TS (18). However, all echocardiography studies were reread by expert echocardiographers
(V.S. and S.S.) with additional measurements of aortic
diameters for the present study.
MRI. Study subjects routinely had cardiac MRI as well as
echocardiography. The thoracic vascular anomalies of the
initial study cohort have previously been reported (19).
Magnetic resonance imaging included cine MRI, black
blood imaging, and velocity-encoded cine phase contrast
pulse sequences. Magnetic resonance imaging studies were
used as a secondary diagnostic modality when the echocardiography reading was uncertain or the aortic valve was not
adequately visualized. Magnetic resonance interpretations
were provided by Drs. Ho and Arai.
Statistical analysis. Data for continuous variables are
shown as means ⫾ standard error and are compared by
analysis of variance or analysis of covariance adjusted for age
and body surface area (BSA) followed by t test. Nominal
data are presented as proportions and compared by chisquare tests. Linear regressions analyzed the correlation
between ascending aortic diameter determined by MRI
versus echocardiography. Statistical significance was a
p value ⬍0.05. Analyses were performed using Stat View for
Windows, version 5.0.1 (SAS Institute Inc., Cary, North
Carolina).
Results
The study included 253 consecutive study subjects that
underwent transthoracic echocardiography. Participants
ranged in age from 7 to 67 years, with 89 subjects ⬍18 years
old. Twenty-five study subjects had had surgical repair of
aortic coarctation during childhood. Transthoracic echocardiography assigned aortic valve diagnoses as follows: 164
tricuspid aortic valve (TAV), 8 probable TAV, 63 BAV, 3
probable BAV, and 15 nonvisualized. One-third of these
BAVs had no visible raphe, and two-thirds were functionally bicuspid with partial or complete fusion of 2 aortic valve
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leaflets along a raphe. Bicuspid valves had “anteriorposterior” configuration (fusion of right and left coronary
cusps) in the great majority of patients (63 of 66). There was
no significant difference in age, weight, or BSA that might
explain the difficulty imaging the aortic valve in the group
designated as nonvisualized by echocardiography.
For the 26 cases where aortic valves were not well
visualized by echocardiography, MRI was used as a supplementary approach. Magnetic resonance imaging was able to
determine valve structure in 12 of 15 cases not visualized on
echocardiography; of these, 8 were BAV and 4 TAV.
Moreover, MRI confirmed a TAV in all 8 “probable” cases
and confirmed BAV in two-thirds of the probable cases.
The third case was too poorly visualized on MRI to
determine valve structure. Based on the high predictive
value of the “probable” echocardiographic diagnosis in the
other cases, we accepted the third case as BAV in subsequent calculations. Thus, in total, echocardiography supplemented with MRI identified 176 of 253 subjects (70%) with
a normal TAV and 74 of 253 (29%) with BAV, and only 3
cases remained undetermined (1%).
Table 1 summarizes characteristics of the groups with
BAV versus TAV. They were similar in age and body size.
The prevalence of BAV in those ⬍18 years of age was 28 of
89, or 31.5%, with 1 case undetermined. This indicates, on
the one hand, that that there is no bias toward detecting
BAV in small girls, and on the other hand, there does not
seem to be any prominent increase in prevalence of abnormal valve structure over time in these patients.
As expected, peak flow through the aortic valve was
greater in the BAV group, as were aortic diameters
(Table 1). Aortic regurgitation was trivial or less in 55%,
mild in ⬃30%, and moderate or severe in ⬃15%. Aortic
Features
Versus
BAV
Associated
in Girls and
With
Women
TAV With TS
Features Associated With TAV
Table 1
Versus BAV in Girls and Women With TS
TAV (n ⴝ 176)

BAV (n ⴝ 74)

28.8 ⫾ 15.2

26.6 ⫾ 14.0

Height (cm)

143.6 ⫾ 11.1

143.3 ⫾ 12.3

0.87

BSA kg/m2

1.44 ⫾ 0.3

1.42 ⫾ 0.3

0.58

Sys BP (mm Hg)

0.9*

Age (yrs)

p Value
0.22

115 ⫾ 11

114 ⫾ 12

Dias BP

69 ⫾ 9

70 ⫾ 9

0.4*

HR (beats/min)

86 ⫾ 11

88 ⫾ 11

0.4*

Peak flow (m/s)

1.30 ⫾ 0.21

1.62 ⫾ 0.66

⬍0.0001*

Annulus (cm)

1.88 ⫾ 0.35

2.07 ⫾ 0.49

0.001*

Sinuses (cm)

2.61 ⫾ 0.39

2.80 ⫾ 0.49

0.003*

Sinotubular junction (cm)

2.11 ⫾ 0.35

2.31 ⫾ 0.46

0.001*

Ascending aorta (cm)

2.34 ⫾ 0.38

2.62 ⫾ 0.63

Dilated aorta†

9/169 (5.3%)

17/69 (25%)

0.002

Neck webbing

43/176 (24%)

33/74 (45%)

0.003

9/176 (5%)

16/74 (22%)

0.002

Aortic coarctation

0.0005*

Data for continuous variables are means ⫾ standard error and are compared by analysis of
variance or *analysis of covariance adjusted for age and body surface area (BSA) followed by t test.
Nominal data are presented as proportions and compared by chi-square tests. †Measurements of
aortic diameter at the sinuses were available for 246 subjects, 8 of whom were too small for the
Roman nomograms.
BAV ⫽ bicuspid aortic valve; Dias BP ⫽ diastolic blood pressure; HR ⫽ heart rate; Sys BP ⫽
systolic blood pressure; TAV ⫽ tricuspid aortic valve; TS ⫽ Turner syndrome.

stenosis was uncommon. Only 2 study subjects had a peak
aortic flow velocity of 3 m/s or greater. One woman had
a velocity of 3 m/s associated with a BAV and moderateto-severe aortic regurgitation. She had undergone an
endovascular valvuloplasty as a child. The second woman
had a BAV with a peak velocity of 5.5 m/s, and had
undergone valvuloplasty in recent years with little improvement. Aortic diameters were greater at all points in
the BAV versus TAV group (Fig. 1A). Diameters at the
sinuses of Valsalva and the sinotubular junction were
plotted against BSA on Roman nomograms (20) to
identify subjects with dilation of the aortic root. Measured at the sinuses, 25% of the BAV group and 5% of the
TAV group had aortic dilation (Table 1). The results for
measurements at the sinotubular junction were similar
(data not shown).
Correlation between echocardiographic and MRI measurement of ascending aortic diameter. Aortic diameter
measurements were systematically acquired by MRI at the
level of the right pulmonary artery origin, which is typically
⬃1.5 cm above the sinotubular junction measurement made
by echocardiography. Simple regression showed a close
correlation between the 2 measurements (Fig. 1B).
Phenotypic and genotypic correlations. There was a
highly significant association between the presence of
neck webbing and BAV, and similarly between aortic
coarctation and BAV (Table 1). The table shows that a
webbed neck is significantly more common in patients
with BAV. To look at it another, more clinically relevant
way, almost 50% of TS patients with neck webbing have
congenital cardiovascular defects. Approximately 31% of
our group of 250 study subjects had neck webbing; of
these, 45% had BAV and/or aortic coarctation, whereas
only 23% of the nonweb group had these defects. The
majority (⬃63%) of study subjects had a pure TS karyotype of 45,X. The 46,XiXq group (IsoQ) have the second
X chromosome missing the short arm (Xp) with 2 copies
of the long arm fused together. Finally, there were small
groups in which the second X chromosome was missing
just the short arm (46,XdelXp; Pdel) or the long arm
(46,XdelXq; Qdel). The prevalence of BAV in the
different karyotype groups is shown in Table 2. Unfortunately, the most informative groups missing just a short
or just a long arm are very small, and thus, statistical
conclusions are limited. One may argue, however, that
these data are more consistent with a locus on the short
arm, Xp. This is because there is a significant increase in
BAV in the groups lacking only the Xp, that is, the Pdel
and IsoQ. Subjects in these karyotype groups are missing
most or all of Xp but have retained the Xq (in the Pdel)
or have an additional copy Xq (in the IsoQ group). Thus,
they are monosomic for Xp only. Although the numbers
are small, the BAV prevalence in these groups is still at
least 10-fold higher than in the 46,XX population (21).
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Figure 1

Effect of AV Morphology on
Ascending Aortic Diameters in Turner Syndrome

(A) Measurements were at the annulus, midpoint of the sinuses of Valsalva,
sinotubular junction (STJ), and ascending aorta (Asc) 1 cm above the STJ. The
box includes the 25th to 75th percentiles and whiskers include the 10th to
90th percentiles. The horizontal line in the box indicates the median, and all
observations less than the 10th and greater than the 90th percentiles are
shown as points. (B) Correlation between Asc diameter measured by echocardiography (Echo AD) and magnetic resonance imaging (MR AD). The echocardiography measurement was 1 cm above the STJ, and the magnetic resonance
imaging measurement was at the level of the right pulmonary artery. The distance between these 2 points is 5 to 10 mm. BAV ⫽ bicuspid aortic valve; TAV
⫽ tricuspid aortic valve.

Discussion
In the present study we have shown that ⬃30% of asymptomatic, unselected female subjects with TS have BAVs,
almost all resulting from fusion of the right and left
coronary leaflets. Previous echocardiographic screening
studies have reported a prevalence of BAV in TS ranging
from 10% to 18.5% (7,8,22–24). There are a few potential
explanations for a lower discovery rate in the previous
studies. The earlier studies were not particularly focused on
the aortic valve and did not describe how many cases were
not adequately visualized. Nor did they report on valve
structure (i.e., leaflet fusion), function, or any association
between abnormal aortic valve and aortic root dilation.
Transthoracic echocardiography has difficulty in visualizing
the aortic valve in 10% to 40% of subjects, especially those
with BAVs (9,10). In the present, highly focused study,
aortic valves were poorly visualized in ⬃5% and nonvisualized in 6% of subjects. However, with cardiac MRI evalu-
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ation of those not well seen on echocardiograms, we were
able to determine aortic valve structure in almost 99% of
study subjects. Interestingly, consistent with prior studies,
we found the majority of aortic valves not captured by
echocardiography to be abnormal. Thus, if early TS studies
had a large proportion of inadequately imaged cases, there
may have been a bias toward reporting normal valves.
Another important difference is that in contrast to the NIH
study, the previous studies included patients with highgrade mosaicism for normal cells. These patients are typically less expressive of most phenotypic features of the
syndrome, so there may have been a true lower prevalence
of BAV.
Selection bias is a potential concern in any prevalence
study. Recruitment to this TS study reflects the current
electronic age in that approximately one-half of the participants found the study by searching the web; the second
largest group of individuals heard about the study by word
of mouth from other participants or at TS support group
meetings. Only about 10% came through medical referrals,
and none of these were specifically related to cardiac
concerns. Most of the adults received care from family
practitioners or gynecologists, and about one-third had
never had any previous cardiac evaluation (25). So it seems
unlikely that we had any particular bias toward cardiac
patients in this study. The prevalence of BAV determined in
the present study pertains to TS individuals that have
survived to age 7 years and older. The prevalence of aortic
valve abnormalities and other congenital defects appears to
be much higher in TS fetuses, with the great majority dying
in utero due to circulatory failure (6,26,27). About 10% of
newborns with TS have very serious cardiovascular defects,
mainly hypoplastic left heart, and survival is poor (24).
Hence, this and other studies evaluating the cardiovascular
system in girls and adults with TS are seeing the survivors,
in whom BAV is often an isolated defect that may not be
clinically detected except by focused screening.
We have shown that the great majority (95.5%) of
abnormal aortic valves in TS result from fusion of right
and left coronary leaflets. This is somewhat different than
in larger BAV populations, in which only 60% to 70%
show fusion of coronary leaflets (28 –30). This particular
valve anatomy was highly associated with left-sided
congenital defects (30). In a smaller previous study, we
demonstrated a strong association between the presence
Genotype and BAV Prevalence
Table 2

Genotype and BAV Prevalence
BAV

TAV

Totals

45,X

57 (36%)

101

158

IsoQ

5 (22%)

18

23

Pdel

1 (9%)

10

11

Qdel

0

4

4

For the sake of clarity, individuals with karyotypes including high-grade mosaicism (i.e., major
contributions from 2 or more cell lines) were excluded from this comparison. See the Results
section for further explanation of these karyotypes.
IsoQ ⫽ 46,XiXq; Pdel ⫽ 46,XdelXp; Qdel ⫽ 46,XdelXq; other abbreviations as in Table 1.
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of neck webbing—the residua of central fetal lymphedema—and cardiovascular defects including BAV and aortic coarctation in TS (18). We have confirmed the
association in the present much larger study. This association was first noted in spontaneously aborted fetuses
with TS that had large cystic hygromas (31). The nuchal
cystic hygromas are collections of lymph associated with
blind-ended jugular lymphatics (26,27,31,32). In fetuses
that survive, the lymphatics develop and hygromas resolve during the latter half of gestation, leaving redundant skin folds of the neck. Clark (31) suggested that
centrally localized distended lymphatics compress the
developing aortic root, resulting in specific left-sided
defects, including hypoplastic left heart, BAV, and coarctation due to low flow, and specific right-sided defects
such as persistent left superior vena cava, anomalous pulmonary
venous return, and dilated right atrium, due to back pressure
from obstruction to forward flow. The present study showing a pattern of anterior-posterior fusion of aortic leaflets
seems consistent with predominantly left-sided outflow
tract defects characteristic of TS.
An alternative explanation for the association between
neck webbing and BAV in TS could be that haploinsufficiency for an X-chromosome gene causes central fetal
lymphedema and aortic heart defects independent of each
other. Haploinsufficiency for an autosomal gene (FOXC2;
16q) causes lymphedema and occasional cardiac defects in
the Lymphedema-Distichiasis syndrome (33). However,
targeted deletion of this gene in mice results in abnormal
aortic arch development without lymphedema (34), suggesting that the heart defects and lymphedema may be
independent effects of haploinsufficiency for FOXC2.
Thus, it is possible that biallelic expression of 1 or more
pseudoautosomal genes located on both X and Y chromosomes is essential for normal cardiovascular development in both genders. There are at least 20 such genes or
putative genes that are expressed from both sex chromosomes and do not undergo inactivation on the supposedly
inactive X. Thus far, we know the function of just 1 of
these genes, SHOX, which is required in 2 copies for
normal skeletal development and longitudinal bone
growth (35). Haploinsufficiency for SHOX results in
⬃20 cm shortfall from the genetically predicted adult
height, while an extra copy, as in Klinefelter syndrome
(47,XXY), results in taller then expected stature. Most
pseudoautosomal genes are located on Xp, consistent with
our observations that the BAV phenotype is associated with
mosomy for Xp specifically.
Bicuspid aortic valve is found in 1% to 2% of the general
population, with a 2-fold higher prevalence in male versus
female patients (21). Given the male predominance, one
might expect an X-linked contribution to risk, and consistent with this view, mutations in the filamin A (FLNA) gene
have been implicated in myxomatous cardiac valve disease
(36). However, the cardiac phenotype in myxomatous val-
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vular dystrophy (OMIM 314400) is very different than in
TS. There are other X-linked genes that might be implicated in cardiovascular development (e.g., the genes encoding VEGF-D and the angiotensin type 2 receptor, both of
which have roles in fetal development). However, if the
increased prevalence of BAV in TS were due to exposure of
a recessive mutation in FLNA or another X-linked gene,
one would expect a frequency of a few percent, as seen in the
male population, not 30%, as we have demonstrated among
girls and women with TS.
We found that ascending aortic dilation, defined as aortic
diameter greater than the 95th percentile for BSA, was
present in 25% of BAV and 5% of TAV subjects with TS,
at both the sinuses of Valsalva and sinotubular junction.
Ascending aortic dilation has been reported in 10% to 40%
of girls and women with TS (11,37– 40), but these previous
studies did not differentiate between those with BAV versus
TAVs. The presence of a BAV is associated with aortic
dilation in the general population, irrespective of valve
functional status (41– 43). For example, in the most recent
study cited, the prevalence of aortic root dilation was 16% at
the sinuses of Valsalva and 18% at the sinotubular junction
for a group of adults with isolated BAV with a mean age of
44 years (43). The association between abnormal aortic
valve anatomy and proximal aortic abnormalities including
coarctation and dilation has shaped the view of a common
underlying developmental defect involving the aortic valve
and the wall of the ascending aorta. The present observations suggest this may be true in TS as well as in nonsyndromic BAV.
The diagnosis of BAV is predominantly determined by
echocardiography, which is, according to our observations,
quite sensitive (66 of 74 ⫽ 89%). Clinicians must insist on
clear visualization of the aortic valve and root, and if not
accomplished by echocardiography, then MRI should be
the next approach. Expertise in cardiac MRI is not so
widespread at present, and referral to a tertiary center may
be necessary to obtain optimal visualization of the aortic
valve (44). Transesophageal echocardiography is an alternative approach (10).

Conclusions
In summary, this study of a very large group of asymptomatic, unselected girls and women with TS has uncovered an
extraordinarily high prevalence of BAV, which is clearly
associated with aortic root dilation. Even though there is no
effective treatment at present, close medical follow-up is
essential to prevent complications such as endocarditis,
aortic dilation and dissection, and to evaluate the severity of
the valvular defects and determine when intervention is
required. Given the high mortality rate of these complications (13), all patients with TS should undergo careful
echocardiographic evaluation for early identification and
follow-up of aortic valve and root abnormalities.
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